loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 208462 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 IXAZOMIB CITRATE (3)

filter

01 TAKEDA PHARMS USA (3)

filter

01 CAPSULE;ORAL (3)

filter

01 EQ 2.3MG BASE (1)

02 EQ 3MG BASE (1)

03 EQ 4MG BASE (1)

filter

01 USA (3)

URL Supplier Web Content
CAPSULE;ORAL
EQ 4MG BASE
NINLARO
USA
208462
2015-11-20
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE;ORAL
EQ 2.3MG BASE
NINLARO
USA
208462
2015-11-20
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE;ORAL
EQ 3MG BASE
NINLARO
USA
208462
2015-11-20
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 208462

Looking for CTD TGA MCC DOSSIER APPLICATION 208462 3

19

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is IXAZOMIB CITRATE, with a corresponding application number 208462 and regulatory information .

proudly manufactured in the

approval since 2015-11-20

Takeda Pharmaceutical's NINLARO CAPSULE;ORAL, medication with EQ 4MG BASE of IXAZOMIB CITRATE.

18

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is IXAZOMIB CITRATE, with a corresponding application number 208462 and regulatory information .

proudly manufactured in the

approval since 2015-11-20

Takeda Pharmaceutical's NINLARO CAPSULE;ORAL, medication with EQ 2.3MG BASE of IXAZOMIB CITRATE.

17

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is IXAZOMIB CITRATE, with a corresponding application number 208462 and regulatory information .

proudly manufactured in the

approval since 2015-11-20

Takeda Pharmaceutical's NINLARO CAPSULE;ORAL, medication with EQ 3MG BASE of IXAZOMIB CITRATE.

Post Enquiry
POST ENQUIRY